Drug
PSMA-11
PSMA-11 is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (100.0%)
Trials by Status
active_not_recruiting267%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_2
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
NCT03181867
active_not_recruiting
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097
unknown
177Lu-PSMA-617 Managed Access Program for mCRPC Patients
NCT04825652
Clinical Trials (3)
Showing 3 of 3 trials
NCT03181867Phase 2
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
NCT07455097
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT04825652
177Lu-PSMA-617 Managed Access Program for mCRPC Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3